Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-030394
Filing Date
2025-03-03
Accepted
2025-03-03 07:05:11
Documents
102
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sndx-20241231.htm   iXBRL 10-K 3293265
2 EX-4.3 sndx-ex4_3.htm EX-4.3 32257
3 EX-10.16 sndx-ex10_16.htm EX-10.16 393123
4 EX-10.28 sndx-ex10_28.htm EX-10.28 16205
5 EX-10.43 sndx-ex10_43.htm EX-10.43 540252
6 EX-19.1 sndx-ex19_1.htm EX-19.1 122931
7 EX-21.SUBSIDIARIES sndx-ex21_subsidiaries.htm EX-21.SUBSIDIARIES 5142
8 EX-23.1 sndx-ex23_1.htm EX-23.1 4762
9 EX-31.1 sndx-ex31_1.htm EX-31.1 15037
10 EX-31.2 sndx-ex31_2.htm EX-31.2 15164
11 EX-32.1 sndx-ex32_1.htm EX-32.1 14960
12 GRAPHIC img208098589_0.jpg GRAPHIC 156186
13 GRAPHIC img208098589_1.jpg GRAPHIC 53473
14 GRAPHIC img208098589_2.jpg GRAPHIC 145349
15 GRAPHIC img208098589_3.jpg GRAPHIC 40218
  Complete submission text file 0000950170-25-030394.txt   14912014

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndx-20241231.xsd EX-101.SCH 1910373
105 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20241231_htm.xml XML 2096221
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37708 | Film No.: 25693737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)